SEC Form 4 · accession 0001209191-18-014733
EXACT SCIENCES CORP · EXAS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Graham Peter Lidgard
Officer — Chief Science Officer
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 7:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001124140
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 26, 2018 | M | 4,587 | $13.96 | A | 211,183 | D | |
| Common StockF2,F3 | Feb 26, 2018 | S | 4,587 | $42.329 | D | 206,596 | D | |
| Common StockF1 | Feb 26, 2018 | M | 13,750 | $5.70 | A | 220,346 | D | |
| Common StockF2,F4 | Feb 26, 2018 | S | 13,750 | $42.188 | D | 206,596 | D | |
| Common StockF5 | Feb 26, 2018 | M | 8,900 | $0.00 | A | 215,496 | D | |
| Common StockF6 | Feb 27, 2018 | S | 4,041 | $44.098 | D | 211,455 | D | |
| Common StockF7 | Feb 27, 2018 | S | 12,647 | $43.45 | D | 198,808 | D | |
| Common Stock | holding | — | — | — | 12,340 | I | Held in 401(K) Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F8 | $13.96 | Feb 26, 2018 | M | 4,587 | D | — | Feb 24, 2024 | Common Stock | 4,587 | 7,163 | D |
| Stock Option (right to buy)F9 | $5.70 | Feb 26, 2018 | M | 13,750 | D | — | Feb 26, 2026 | Common Stock | 13,750 | 27,500 | D |
| Restricted Stock UnitsF10,F11 | — | Feb 26, 2018 | M | 8,900 | D | — | — | Common Stock | 8,900 | 17,800 | D |
| Stock Option (right to buy)F12 | $44.37 | Feb 27, 2018 | A | 16,700 | A | Feb 27, 2019 | Feb 27, 2028 | Common Stock | 16,700 | 16,700 | D |
| Restricted Stock UnitsF10,F13 | — | Feb 27, 2018 | A | 20,100 | A | — | — | Common Stock | 20,100 | 20,100 | D |
Explanation of responses
- F1Represents shares of common stock received upon exercise of a stock option award.
- F10Each restricted stock unit represents a contingent right to receive one share of common stock.
- F11Represents a restricted stock unit award granted on February 26, 2016 that partially vested on February 26, 2018. The restricted stock units vest in four equal annual installments beginning on February 26, 2017.
- F12This option vests and becomes exercisable in four equal annual installments beginning on the first anniversary of the grant date.
- F13These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.55, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.525, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
- F5Represents shares of common stock received upon vesting of a restricted stock unit award.
- F6Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 26, 2018.
- F7The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017.
- F8This option vests and becomes exercisable in four equal annual installments beginning on February 24, 2015.
- F9This option vests and becomes exercisable in four equal annual installments beginning on February 26, 2017.